TEST BANK V
Pharmacology for the Primary Care Provider, 4t
V V V V V V
h Edition by Marilyn Winterton Edmunds a
V V V V V V
nd Maren Stewart Mayhew
V V V
TEST BANK V
, PharmacologyVforVtheVPrimaryVCareVProvider,V4thVEditionVbyVMarilynV
WintertonVEdmundsVandVMarenVStewartVMayhewVTestVBank
TableVofVContent
PARTVONE:VESSENTIALVCONCEPTSVFORVTHEVPRESCRIPTIONVOFVMEDICAT
IONS
UnitV1:VFoundationsVofVPrescriptiveVPractice
1.VPrescriptiveVAuthorityVandVRoleVImplementation:VTraditionVvs.VChange
2.VHistoricalVReviewVofVPrescriptiveVAuthority:VTheVRoleVofVNursesV(NPs,VCNMs,VCRNA
s,VandVCNSs)VandVPhysicianVAssistants
UnitV2:VPharmacokineticsVandVPharmacodynamics
3.VGeneralVPharmacokineticVandVPharmacodynamicVPrinciples
4.VSpecialVPopulations:VGeriatrics
5.VSpecialVPopulations:VPediatrics
6.VSpecialVPopulations:VPregnantVandVNursingVWomen
7.VOver-the-CounterVMedications
8.VComplementaryVandVAlternativeVTherapies
UnitV3:VTheVArtVandVScienceVofVPharmacotherapeutics
9.VEstablishingVtheVTherapeuticVRelationship
10.VPracticalVTipsVonVWritingVPrescriptions
11.VEvidence-BasedVDecision-MakingVandVTreatmentVGuidelines
12.VDesignVandVImplementationVofVPatientVEducation
PARTVTWO:VDRUGVMONOGRAPHS
UnitV4:VTopicalVAgents
13.VDermatologicVAgents
14.VEye,VEar,VThroat,VandVMouthVAgents
UnitV5:VRespiratoryVAgents
15.VUpperVRespiratoryVAgents
16.VAsthmaVandVChronicVObstructiveVPulmonaryVDiseaseVMedications
UnitV6:VCardiovascularVAgents
17.VHypertensionVandVMiscellaneousVAntihypertensiveVMedications
18.VCoronaryVArteryVDiseaseVandVAntianginalVMedications
19.VHeartVFailureVandVDigoxin
20.Vß-Blockers
21.VCalciumVChannelVBlockers
22.VACEVInhibitorsVandVAngiotensinVReceptorVBlockers
23.VAntiarrhythmicVAgents
,24.VAntihyperlipidemicVAgents
25.VAgentsVthatVActVonVBlood
UnitV7:VGastrointestinalVAgents
26.VAntacidsVandVtheVManagementVofVGERD
27.VHistamine-2VBlockersVandVProtonVPumpVInhibitors
28.VLaxatives
29.VAntidiarrheals
30.VAntiemetics
31.VMedicationsVforVIrritableVBowelVSyndromeVandVOtherVGastrointestinalVProblems
UnitV8:VRenal/GenitourinaryVAgents
32.VDiuretics
33.VMaleVGenitourinaryVAgents
34.VDrugsVforVUrinaryVIncontinenceVandVUrinaryVAnalgesia
UnitV9:VMusculoskeletalVAgents
35.VAcetaminophen
36.VAspirinVandVNonsteroidalVAntiinflammatoryVDrugs
37.VDisease-ModifyingVAntirheumaticVDrugsVandVImmuneVModulators
38.VGoutVMedications
39.VOsteoporosisVTreatment
40.VMuscleVRelaxants
UnitV10:VCentralVNervousVSystemVAgents
41.VMedicationsVforVAttentionVDeficitVHyperactivityVDisorder
42.VMedicationsVforVDementia
43.VAnalgesiaVandVPainVManagement
44.VMigraineVMedications
45.VAntiepileptics
46.VAntiparkinsonVAgents
UnitV11:VPsychotropicVAgents
47.VAntidepressants
48.VAntianxietyVandVAntiinsomniaVAgents
49.VAntipsychotics
50.VSubstanceVAbuse
UnitV12:VEndocrineVAgents
51.VGlucocorticoids
52.VThyroidVMedications
53.VDiabetesVMellitusVAgents
UnitV13:VReproductiveVSystemVMedications
54.VContraceptives
, 55.VHormoneVReplacementVTherapyV–VNEWVTitle/Focus!
56.VDrugsVforVBreastVCancer
UnitV14:VAntiinfectives
57.VPrinciplesVforVPrescribingVAntiinfectives
58.VTreatmentVofVSpecificVInfectionsVandVMiscellaneousVAntibiotics
59.VPenicillins
60.VCephalosporins
61.VTetracyclines
62.VMacrolides
63.VFluoroquinolones
64.VAminoglycosides
65.VSulfonamides
66.VAntitubercularVAgents
67.VAntifungals
68.VAntiretroviralVMedications
69.VAntiviralVandVAntiprotozoalVAgents
UnitV15:VHealthVPromotion
70.VImmunizationsVandVBiologicals
71.VWeightVManagement
72.VSmokingVCessation
73.VVitaminsVandVMinerals
Pharmacology for the Primary Care Provider, 4t
V V V V V V
h Edition by Marilyn Winterton Edmunds a
V V V V V V
nd Maren Stewart Mayhew
V V V
TEST BANK V
, PharmacologyVforVtheVPrimaryVCareVProvider,V4thVEditionVbyVMarilynV
WintertonVEdmundsVandVMarenVStewartVMayhewVTestVBank
TableVofVContent
PARTVONE:VESSENTIALVCONCEPTSVFORVTHEVPRESCRIPTIONVOFVMEDICAT
IONS
UnitV1:VFoundationsVofVPrescriptiveVPractice
1.VPrescriptiveVAuthorityVandVRoleVImplementation:VTraditionVvs.VChange
2.VHistoricalVReviewVofVPrescriptiveVAuthority:VTheVRoleVofVNursesV(NPs,VCNMs,VCRNA
s,VandVCNSs)VandVPhysicianVAssistants
UnitV2:VPharmacokineticsVandVPharmacodynamics
3.VGeneralVPharmacokineticVandVPharmacodynamicVPrinciples
4.VSpecialVPopulations:VGeriatrics
5.VSpecialVPopulations:VPediatrics
6.VSpecialVPopulations:VPregnantVandVNursingVWomen
7.VOver-the-CounterVMedications
8.VComplementaryVandVAlternativeVTherapies
UnitV3:VTheVArtVandVScienceVofVPharmacotherapeutics
9.VEstablishingVtheVTherapeuticVRelationship
10.VPracticalVTipsVonVWritingVPrescriptions
11.VEvidence-BasedVDecision-MakingVandVTreatmentVGuidelines
12.VDesignVandVImplementationVofVPatientVEducation
PARTVTWO:VDRUGVMONOGRAPHS
UnitV4:VTopicalVAgents
13.VDermatologicVAgents
14.VEye,VEar,VThroat,VandVMouthVAgents
UnitV5:VRespiratoryVAgents
15.VUpperVRespiratoryVAgents
16.VAsthmaVandVChronicVObstructiveVPulmonaryVDiseaseVMedications
UnitV6:VCardiovascularVAgents
17.VHypertensionVandVMiscellaneousVAntihypertensiveVMedications
18.VCoronaryVArteryVDiseaseVandVAntianginalVMedications
19.VHeartVFailureVandVDigoxin
20.Vß-Blockers
21.VCalciumVChannelVBlockers
22.VACEVInhibitorsVandVAngiotensinVReceptorVBlockers
23.VAntiarrhythmicVAgents
,24.VAntihyperlipidemicVAgents
25.VAgentsVthatVActVonVBlood
UnitV7:VGastrointestinalVAgents
26.VAntacidsVandVtheVManagementVofVGERD
27.VHistamine-2VBlockersVandVProtonVPumpVInhibitors
28.VLaxatives
29.VAntidiarrheals
30.VAntiemetics
31.VMedicationsVforVIrritableVBowelVSyndromeVandVOtherVGastrointestinalVProblems
UnitV8:VRenal/GenitourinaryVAgents
32.VDiuretics
33.VMaleVGenitourinaryVAgents
34.VDrugsVforVUrinaryVIncontinenceVandVUrinaryVAnalgesia
UnitV9:VMusculoskeletalVAgents
35.VAcetaminophen
36.VAspirinVandVNonsteroidalVAntiinflammatoryVDrugs
37.VDisease-ModifyingVAntirheumaticVDrugsVandVImmuneVModulators
38.VGoutVMedications
39.VOsteoporosisVTreatment
40.VMuscleVRelaxants
UnitV10:VCentralVNervousVSystemVAgents
41.VMedicationsVforVAttentionVDeficitVHyperactivityVDisorder
42.VMedicationsVforVDementia
43.VAnalgesiaVandVPainVManagement
44.VMigraineVMedications
45.VAntiepileptics
46.VAntiparkinsonVAgents
UnitV11:VPsychotropicVAgents
47.VAntidepressants
48.VAntianxietyVandVAntiinsomniaVAgents
49.VAntipsychotics
50.VSubstanceVAbuse
UnitV12:VEndocrineVAgents
51.VGlucocorticoids
52.VThyroidVMedications
53.VDiabetesVMellitusVAgents
UnitV13:VReproductiveVSystemVMedications
54.VContraceptives
, 55.VHormoneVReplacementVTherapyV–VNEWVTitle/Focus!
56.VDrugsVforVBreastVCancer
UnitV14:VAntiinfectives
57.VPrinciplesVforVPrescribingVAntiinfectives
58.VTreatmentVofVSpecificVInfectionsVandVMiscellaneousVAntibiotics
59.VPenicillins
60.VCephalosporins
61.VTetracyclines
62.VMacrolides
63.VFluoroquinolones
64.VAminoglycosides
65.VSulfonamides
66.VAntitubercularVAgents
67.VAntifungals
68.VAntiretroviralVMedications
69.VAntiviralVandVAntiprotozoalVAgents
UnitV15:VHealthVPromotion
70.VImmunizationsVandVBiologicals
71.VWeightVManagement
72.VSmokingVCessation
73.VVitaminsVandVMinerals
